Advertisement

Patient-Reported Outcomes in Health Economic Decision-Making: A Changing Landscape in Oncology

  • Mandi Pratt-ChapmanEmail author
  • Afsan Bhadelia
Chapter
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 213)

Abstract

Cancer causes significant death and disability globally. However, costs of more personalized cancer care continue to climb, while access to basic cancer screening and treatment is not available to much of the world. This chapter provides an overview of the status of patient-reported outcomes (PROs) in cancer clinical care and research. PROs are valuable for health care and health economic decision-making at institutional, regional, national, and international levels. PRO data should be considered along with cost and survival data when approving new therapies. PRO data can also be helpful when assessing existing treatment options for patients, particularly for drugs with minor outcome and toxicity differences. Finally, PROs can be useful in reimbursement algorithms to ensure delivery of quality cancer care in value-based financing environments. The authors advocate for reframing the concept of health value, aligning PRO measures with societal values, and broadening the definition of society to extend beyond national boundaries.

Keywords

Patient-reported outcomes PROs Cost Patient-centered care Health economics Cost Value Cancer 

References

  1. Alexander B, Gurian G, Tilghman-Bryant T, Al E (2014) The societal and economic impact of cancer health disparities. Washington DCGoogle Scholar
  2. American Cancer Society (2016) Cancer Facts and Figures 2016. American Cancer Society, AtlantaGoogle Scholar
  3. Ayanian JZ, Zaslavsky AM, Arora NK, Kahn KL, Malin JL, Ganz PA, van Ryn M, Hornbrook MC, Kiefe CI, He Y, Urmie JM, Weeks JC, Harrington DP (2010) Patients’ experiences with care for lung cancer and colorectal cancer: findings from the cancer care outcomes research and surveillance consortium. J Clin Oncol 28(7):4154–4161.  https://doi.org/10.1200/JCO.2009.27.3268CrossRefPubMedPubMedCentralGoogle Scholar
  4. Balint E (1968) The possibilities of patient-centered medicine. Paper presented at the symposium conducted at the American Psychiatric Association, New Orleans, LAGoogle Scholar
  5. Beach MC, Saha S, Cooper LA (2006) The role and relationship of cultural competence and patient-centeredness in health care quality. Commonwealth Fund 960:1–22Google Scholar
  6. Bhadelia A, Atun R, Knaul FM (n.d.) Value of Cancer Care and Caring, MimeoGoogle Scholar
  7. Brogan AP, DeMuro C, Barrett AM, D’Alessio D, Bal V, Hogue SL (2017) Payer perspectives on patient-reported outcomes in health care decision-making: oncology examples. J Manag Care Spec Pharm 23(2):125–134PubMedGoogle Scholar
  8. Brooks GA, Cronin AM, Uno H, Schrag D, Keating NL, Mack JW (2016) Intensity of medical interventions between diagnosis and death in patients with advanced lung and colorectal cancer: a cancors analysis. J Palliative Medicine 19(1):42–50CrossRefGoogle Scholar
  9. Brown JB, Stewart MA, Ryan BL (2001) Assessing communication between patients and physicians: the measure of patient-centered communication (MPCC). Working Paper Series, Paper # 95–2, 2nd edn. London, Ontario, Canada; Thames Valley Family Practice Research Unit and Centre for Studies in Family MedicineGoogle Scholar
  10. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1994) The edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9Google Scholar
  11. Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) (n.d.) The cancer care outcomes research and surveillance consortium: share thoughts on care. Retrieved from http://www.cancors.org/public/
  12. Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D (2013) Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a cancer care outcomes research and surveillance consortium (CanCORS) study. J Clin Oncol 31(5):558–564CrossRefGoogle Scholar
  13. Chrischilles EA, McDowell BD, Rubenstein L, Charlton M, Pendergast J, Juarez GY, Arora NK (2015) Survivorship care planning and its influence on long-term patient-reported outcomes among colorectal and lung cancer survivors: the CanCORS disease-free survivor follow-up study. J Cancer Surviv Res Pract 9(2):269–278CrossRefGoogle Scholar
  14. Cleary PD, Edgman-Levitan S, Roberts M, Moloney TW, McMullen W, Walker JD, Delbanco TL (1991) Patients evaluate their hospital care: a national survey. Health Aff 10(4):254–267CrossRefGoogle Scholar
  15. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle M, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M. D Anderson symptom inventory. Cancer 89:1634–1646CrossRefGoogle Scholar
  16. Cleeland CS, Sloan JA (2010) Assessing the symptoms of cancer using patient-reported outcomes (ascpro): searching for standards. J Pain Symptom Manage 39(6):1077–1085CrossRefGoogle Scholar
  17. Coyle J, Williams B (2001) Valuing people as individuals: development of an instrument through a survey of person centredness in secondary care. J Adv Nurs 36:450–455CrossRefGoogle Scholar
  18. del Piccolo L, Mazzi MA, Scardoni S, Gobbi M, Zimmerman C (2008) A theory-based proposal to evaluate patient-centered communication in medical consultations: the verona patient-centered communication evaluation scale (VR-COPE). Health Educ 108(5):355–372Google Scholar
  19. Donaldson MS (2004) Taking stock of health-related quality-of-life measurement in oncology practice in the United States. J Natl Cancer Inst Monogr 2004(33):155–167CrossRefGoogle Scholar
  20. Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R (2009) Development and initial validation of an expanded and revised version of the short-form McGill pain questionnaire (SF-MPQ-2). Pain 144:35–42CrossRefGoogle Scholar
  21. Edvardsson D, Koch S, Nay R (2009) Psychometric evaluation of the English language person-centered climate questionnaire–patient version. West J Nurs Res 31:235–444CrossRefGoogle Scholar
  22. Efficace F, Rees J, Fayers P, Pusic A, Taphoorn M, Greimel E, Reijneveld J, Whale K, Blazeby J (2014) Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION registry. Health Qual Life Outcomes 12:86.  https://doi.org/10.1186/1477-7525-12-86CrossRefGoogle Scholar
  23. Epstein RM, Peters E (2009) Beyond information: exploring patients’ preferences. J Am Med Assoc 302(2):195–197CrossRefGoogle Scholar
  24. European Medicines Agency (2014) Reflection paper on the use of patient reported outcomes (PRO) measures in oncology studiesGoogle Scholar
  25. Gimema QOL Working Party (n.d.) PROMOTION registry. http://promotion.gimema.it/
  26. Glasgow RE, Wagner EH, Schaefer J et al (2005) Development and validation of the patient assessment of chronic illness care (PACIC). Med Care 43(5):436CrossRefGoogle Scholar
  27. Gnanasakthy A, DeMuro C (2015) Overcoming organizational challenges of integrating patient-reported outcomes in oncology clinical trials. Ther Innov Regul Sci 49(6):822–830CrossRefGoogle Scholar
  28. Gnanasakthy A, DeMuro C, Clark M, Haydysch E, Ma E, Bonthapally V (2016) Patient-reported outcomes labeling for products approved by the office of hematology and oncology products of the us food and drug administration (2010–2014). J Clin Oncol 34(15):1928–1934CrossRefGoogle Scholar
  29. Goeree R, Diaby V (2013) Introduction to health economics and decision-making: is economics relevant for the frontline clinician? Best Pract Res Clin Gastroenterol 27:831–844CrossRefGoogle Scholar
  30. Goldstein DA, Clark J, Tu Y, Zhang J, Fang F, Goldstein RM, Stemmer SM, Rosenbaum E (2016) Global differences in cancer drug prices: a comparative analysis. J Clin Oncol Suppl Abstr LBA6500Google Scholar
  31. Gondek K, Sagnier P, Gilchirst K, Woolley JM (2007) Current status of patient reported outcomes in industry sponsored oncology clinical trials and product labels. J Clin Oncology 25(32):5087–5093CrossRefGoogle Scholar
  32. Hamidou Z, Dabakuyo TS, Bonnetain F (2011) Impact of response shift on longitudinal quality of life assessment in cancer clinical trials. Expert Rev Phamacoecon Outcomes Res 11(5):549–559.  https://doi.org/10.1586/erp.11.57CrossRefGoogle Scholar
  33. Henbest RJ, Stewart MA (1989) Patient-centredness in the consultation a method for measurement. Fam Pract 6:249–253CrossRefGoogle Scholar
  34. Holzner B, Kemmler G, Sperner-Unterweger B, Kopp M, Dunser M, Margreiter R, Marschitz I, Nachbaur D, Fleischhacker WW, Griel R (2001) Quality of life measurement in oncology—a matter of the assessment instrument? Eur J Cancer 37:2349–2356CrossRefGoogle Scholar
  35. IMMPACT. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (n.d.) Retrieved from www.immpact.org/index.html
  36. IMS Institute for Healthcare Informatics (2016) Global oncology trend report: a review of 2015 and outlook to 2020. IMS Institute for Healthcare Informatics, ParsippanyGoogle Scholar
  37. Institute of Medicine (2001) Crossing the quality chasm. National Academies Press, Washington, DCGoogle Scholar
  38. Institute of Medicine (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. National Academies Press, WashingtonGoogle Scholar
  39. Institute of Medicine, Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care (2003) Smedley BD, Stith AY NA (eds), Unequal treatment: confronting racial and ethnic disparities in health care. National A. National Academies Press, Washington, DC.  https://doi.org/10.17226/12875
  40. Kenzik KM, Ganz PA, Martin MY, Petersen L, Hays RD, Arora N, Pisu M (2015) How much do cancer-related symptoms contribute to health-related quality of life in lung and colorectal cancer patients? a report from the cancer care outcomes research and surveillance (CanCORS) consortium. Cancer 121(16):2831–2839 PMID: 25891437CrossRefGoogle Scholar
  41. Kluetz PG, Slagle A, Papadopoulos EJ, Johnson LL, Donoghue M, Kwitkowski VE, Chen W, Sridhara R, Farrell AT, Keegan P, Kim G, Pazdur R (2016) Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms. Clin Cancer Res 22(7):1553–1558.  https://doi.org/10.1158/1078-0432.CCR-15-2035CrossRefPubMedGoogle Scholar
  42. Laschinger HS, Hall LM, Pedersen CP, Almost J (2005) A psychometric analysis of the patient satisfaction with nursing care quality questionnaire. J Nurs Care Qual 20:220–230CrossRefGoogle Scholar
  43. Lipscomb J, Gotay CC, Snyder CF (2007) Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA A Cancer J Clin 57(5):278CrossRefGoogle Scholar
  44. Litzelman Kristin, Kent Erin E, Rowland Julia H (2016) Social factors in informal cancer caregivers: The interrelationships among social stressors, relationship quality, and family functioning in the CanCORS data sete. Cancer 122(2):278–286CrossRefGoogle Scholar
  45. Loftus P, Winslow R (2015, Oct 1) FDA approves Bristol-Myers’s Yervoy, Opdivo for treatment of melanoma. Wall Street JGoogle Scholar
  46. MAPI Research Trust (n.d.) Patient reported outcome and quality of life instrument database. Retrieved from http://www.proqolid.org/
  47. Mariotto AB, Robin Yabroff K, Shao Y, Feuer EJ, Brown ML (2011) Projections of the cost of cancer care in the United States: 2010–2020. JNCI J Natl Cancer Inst 103:117–128.  https://doi.org/10.1093/jnci/djq495CrossRefPubMedGoogle Scholar
  48. Morgan S, Yoder LH (2012) A concept analysis of person-centered care. J Holist Nurs 30(1):6–15CrossRefGoogle Scholar
  49. National Institutes of Health (n.d.) Grid enabled measures database. https://www.gem-beta.org/Public/MeasureList.aspx?cat=2&viewall=false&scont=10
  50. National Institutes of Health (n.d.) Patient-reported outcomes measurement information system: dynamic tools to measure health outcomes from the patient perspective. Retrieved from www.nihPROMIS.org
  51. Patient Advocate Foundation (n.d.) Consumer-based cancer care value index. Retrieved from https://www.patientvalueindex.org/admin.php?register=center
  52. Pratt-Chapman M, Hoffler E, Dor A, Sotomayor E (2015) ASCO’s value framework: is it all about the drugs? Value-Based Cancer Care 6:9Google Scholar
  53. Ramsay J, Campbell JL, Schroter S, Green J, Roland M (2000) The general practice assessment survey (GPAS): tests of data quality and measurement properties. Fam Pract 17:372–379CrossRefGoogle Scholar
  54. Rock EP, Scott JA, Kennedy DL, Sridhara R, Pazdur R, Burke LB (2007) Challenges to use of health-related quality of life for food and drug administration approval of anticancer products. J Natl Cancer Inst Monogr 37:27–30CrossRefGoogle Scholar
  55. Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, Ware JE (1998) The primary care assessment survey: tests of data quality and measurement performance. Med Care 36:728–739CrossRefGoogle Scholar
  56. Schnipper LE, Davidson NE, Wollins DS, Tyne S, Blayney DW, Blum D et al (2015) American society of clinical oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol 33(23):2563–2577CrossRefGoogle Scholar
  57. Sheikh K, Ranson MK, Gilson L (2014) Explorations on people centredness in health systems. Health Policy Plann 29(suppl_2)Google Scholar
  58. Sloan JA, Berk L, Roscoe J, Fisch MJ, Shaw EG, Wyatt G, Morrow GR, Dueck AC (2007) Integrating Patient-Reported Oucomes into cancer symptom management clinical trials supported by the national cancer institute-sponsored clinical trials networks. J Clin Oncol 25(32):5070–5077CrossRefGoogle Scholar
  59. Stewart M, Brown JB, Weston WW, McWilliam CL, Freeman TR (1995) Patient-centered medicine: transforming the clinical method. Sage, Thousand Oaks, CAGoogle Scholar
  60. Suhonen R, Leino-Kilpi H, Välimäki M (2005) Development and psychometric properties of the individualized care scale. J Eval Clin Pract 11:7–20CrossRefGoogle Scholar
  61. Sullivan DR, Forsberg CW, Ganzini L, Au DH, Gould MK, Provenzale D, Lyons KS, Slatore CG (2016) Depression symptom trends and health domains among lung cancer patients in the CanCORS study. Lung Cancer 100:102–109.  https://doi.org/10.1016/j.lungcan.2016.08.008CrossRefPubMedPubMedCentralGoogle Scholar
  62. Unsworth CA (2001) Selection for rehabilitation: acute discharge patterns for stroke and orthopedic patients. Int J Rehabil Res 24:103–114CrossRefGoogle Scholar
  63. U.S. Department of Health and Human Services (2009) Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. Food and Drug AdministrationGoogle Scholar
  64. Vodicka E, Kim K, Devine EB, Gnanasakthy A, Scoggins JF, Patrick DL (2015) Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.com
  65. Ware JE, Bayliss MS, Mannocchia M, Davis GL (1999) Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. Intervent Ther Group Hepatol 30:550–555Google Scholar
  66. Ware JE (n.d.) SF-36® Health survey update. Retrieved from http://www.sf-36.org/tools/sf36.shtml#LIT
  67. World Health Organization (2015) Cancer control: a global snapshot in 2015: summary of results from the 2015 WHO NCD country capacity surveyGoogle Scholar
  68. Zagadailov E, Fine M, Shields A (2013) Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers. Am Health Drug Benefits 6(5):264–274PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.The George Washington University, GW Cancer CenterWashingtonUSA
  2. 2.Harvard T.H. Chan School of Public HealthBostonUSA
  3. 3.Johns Hopkins School of Public HealthBaltimoreUSA

Personalised recommendations